Story Navigation
-
DiscoveryCancerCell and Gene TherapyNovartis Institutes for BioMedical ResearchClinical ResearchClinical Trials
Researchers boost understanding of T-cell therapy in blood cancer
Novartis investigators find genetic explanations for why some young patients relapse.
Discovery -
DiscoveryDiseasesDrug DiscoveryNovartis Institutes for BioMedical ResearchDrug Development
Teaming up with academia to discover medicines
The Novartis Faculty of Scholars initiative connects academic researchers with deep knowledge and big ideas to scientists in its drug discovery labs.
Discovery -
DiscoveryDrug DiscoveryEmerging TechnologyInnovationNovartis Institutes for BioMedical ResearchDrug Development
New drug manufacturing tools change pharma chemistry
The modernization and miniaturization of pharmaceutical production could expand the range of ingredients medicinal chemists use to make new drugs.
Discovery -
DiscoveryChronic IllnessDigitalDiseasesNovartis Institutes for BioMedical ResearchNew Scientific DiscoveriesScientific Research
Embracing big data to understand complex diseases
Researchers discover that networks of proteins circulating in the blood influence the development and progression of chronic diseases.
Discovery -
DiscoveryDiseasesDrug DiscoveryNovartis Institutes for BioMedical ResearchScientific ResearchGenetic Disease
Discovery gives cystic fibrosis researchers new direction
Novartis-Harvard team identifies a new type of cell that is key to the disease.
Discovery -
DiscoveryDigitalDrug DiscoveryNeuroscienceNovartis Institutes for BioMedical ResearchClinical TrialsDrug Development
Quest for a new measure of mental health
Novartis researchers are searching for more effective ways to discover drugs for neurological and psychiatric diseases.
Discovery -
DiscoveryDigitalEmerging TechnologyInnovationReimagine MedicineScientific ResearchDrug Development
Drug development gets big data analytics boost
With Nerve Live, Novartis is harnessing the power of data for the benefit of patients.
Discovery -
DiscoveryOncologyWomen in ScienceWorking at NovartisReimagine MedicineCareers
Women in Science: Kristen Harrington-Smith
Kristen Harrington-Smith discusses her work as Vice President and Head of CAR-T US at Novartis Oncology.
Discovery -
DiscoveryDrug DiscoveryInfectious DiseasesInnovationNext Generation ScientistNovartis Institutes for BioMedical Research
Open resources at Novartis help drive innovation
With external help from Novartis, an Argentinian researcher was able to begin his search for a new medicine for tuberculosis.
Discovery -
DiscoveryCancerNovartis Institutes for BioMedical ResearchOncologyTargeted TherapyClinical Research
Immuno-oncology researchers seek to build smart drug combos
Novartis has launched a comprehensive research program to help find the right combinations of therapies for the right patients.
Discovery -
DiscoveryDigitalOncologyWomen in ScienceWorking at NovartisReimagine MedicineCareers
Women in Science: Mimi Huizinga
Meet our Vice President of Strategic Data and Digital at Novartis Oncology.
Discovery -
DiscoveryDigitalDrug DiscoveryInnovationNovartis Institutes for BioMedical ResearchDrug Development
Machine learning poised to accelerate drug discovery
Technology used to tag friends on social media could change the way drug discovery is done.
Discovery
Pagination
- ‹ Previous page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- …
- 13
- › Next page